- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/04 - Antibacterial agents
Patent holdings for IPC class A61P 31/04
Total number of patents in this class: 13148
10-year publication summary
|
470
|
491
|
522
|
877
|
1017
|
1189
|
1295
|
1242
|
1094
|
442
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1701 |
124 |
| King Faisal University | 409 |
95 |
| Centre National de La Recherche Scientifique | 9632 |
92 |
| The Regents of the University of California | 18943 |
90 |
| Pfizer Inc. | 3322 |
62 |
| iNtRON Biotechnology, Inc. | 176 |
62 |
| Novartis AG | 11238 |
60 |
| Hoffmann-La Roche Inc. | 3060 |
57 |
| Wockhardt Limited | 239 |
56 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
52 |
| Intervet Inc. | 848 |
52 |
| Intervet International B.V. | 1235 |
51 |
| Shionogi & Co., Ltd. | 914 |
50 |
| Merck Sharp & Dohme LLC | 3689 |
49 |
| Daiichi Sankyo Company, Limited | 1829 |
46 |
| President and Fellows of Harvard College | 5792 |
45 |
| ContraFect Corporation | 91 |
45 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
41 |
| F. Hoffmann-La Roche AG | 7958 |
40 |
| Mondobiotech Laboratories AG | 311 |
37 |
| Other owners | 11942 |